SHIRE HUMAN GENETIC THERAPIES, INC. sold 0.6% of their position (40.09K shares) of TRANSLATE BIO, INC. on the open market
Open‑market sale worth $791.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/5/2020ACC: 0001395064-20-000084
10% Owner
Since Jul 2018
-40.09K
Net shares
Net seller
$791.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
40.09K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−40.09K
Price / share
$19.75
Trade value
$791.70K
% of position
0.6%
6/3/2020
6.87M→6.82M
Total
Net shares
−40.09K
Net value
-$791.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/3/2020 | S · Sale | −40.09K | $19.75 | $791.70K | 0.6% | 6.87M | 6.82M |
| Total | −40.09K | -$791.70K | ||||||
Derivative Transactions0
No derivative transactions reported